Why the study?
The study evaluated the performances of female middle- and long-distance runners before and after implementing the Athlete Biological Passport in a country accused of systematic doping.
Does the implementation of the Athlete Biological Passport reduce the performance of female elite runners in a country accused of systematic doping?
Does the implementation of the Athlete Biological Passport reduce the performance of female elite runners in a country accused of systematic doping?
The implementation of the Athlete Biological Passport was associated with a significant reduction in the performance of female elite runners in Russia, suggesting the efficacy of more stringent antidoping testing.
May indicate ABP curbs doping-related gains in elite runners; leaves open causal effects beyond this single-nation retrospective analysis.
The purpose of this research was to evaluate the performances of female middle- and long-distance runners before and after the implementation of a new antidoping strategy (the Athlete Biological Passport [ABP]) in a country accused of systematic doping. A retrospective analysis of the results of Russian National Championships from 2008 to 2017 was performed. The 8 best female performances for the 800-m, 1500-m, 3000-m steeplechase, 5000-m, and 10,000-m events from the semifinals and finals were analyzed. The yearly number of athletes fulfilling standard qualifications for international competitions was also evaluated. Overall, numbers of athletes banned for doping in 2008-2017 were calculated. As a result, 4 events (800, 1500, 5000 [all P < .001], and 10,000 m [P < .01]) out of 5 showed statistically significant deterioration in the performances when comparing before and after the introduction of the ABP. The 3000-m steeplechase was the only event that did not show statistically significant change. The highest relative decrease in the number of runners who met standard qualification for international competition was for the 5000-m event (46%), followed by 1500-m (42%), 800-m (38%), 10,000-m (17%), and 3000-m steeplechase (1%). In conclusion, implementation of the ABP was followed by a significant reduction in the performance of female runners in a country accused of systematic doping. It can be reasonably speculated that more stringent antidoping testing, more specifically the introduction of the ABP, is a key reason for this reduction.
No takes yet. Share an insight, caveat, or question.
Iljukov et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: